FDA posts press releases and other notices of recalls from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

Maxair Inhaler Recalled

NEWS RELEASE



Contact:  John Cornwell
          651/733-7698
          Fax: 651/575-0616

For Immediate Release

Maxair Inhaler Recalled

ST. PAUL, Minn.--(BW HealthWire)--May 8, 2002--3M Pharmaceuticals Division today announced a voluntary recall of the prescription medication Maxair Inhaler (pirbuterol acetate inhalation aerosol). This is a press-and-breathe metered-dose inhaler. The lot numbers are 000644, 000756, 000947, 001009, 001110, 001111, 010025, 010195, 010283, 010413, 010414, 010482, 010580, 010708, 010709, 011210. The recall has been issued as a precaution to address the remote possibility that a Maxair press-and-breathe aerosol inhaler may stick intermittently and patients may not receive the expected puff of medication.

This recall does not affect Maxair Autohaler (pirbuterol acetate inhalation aerosol), a breath-actuated metered-dose inhaler.

Patients currently using the Maxair press-and-breathe inhaler are advised to return the product to their pharmacy. 3M is unable to offer patients an exact replacement unit at this time, as the Maxair press-and-breathe inhaler is currently unavailable. Patients can obtain the same medication in a different delivery device. 3M will provide Maxair autohaler (pirbuterol acetate inhalation aerosol), a breath-actuated inhaler (200 mcg pirbuterol/ inhalation), free of charge in exchange for the Maxair press-and-breathe inhaler (200 mcg pirbuterol/inhalation). A physician prescription will be required to obtain a Maxair autohaler or any other inhaler replacement.

The recall is being conducted with the knowledge of the U. S. Food and Drug Administration.

3M Pharmaceuticals has provided a dedicated toll-free number to respond to questions from patients and physicians. The toll-free number is 1-800-390-1132. This line is available seven days a week, 8:30 a.m. to 5 p.m. EDT.

Recall Notices


Recalls Home | FDA Home Page | Search | A-Z Index | Site Map | Contact FDA

FDA/Website Management Staff
Web page created by tg 2002-MAY-09.